Can AI remedy the growing pains of digital biomarker development?
AI implementation could be a useful tool to analyse generated data. Yet, regulatory approval hurdles are in sight.
By
AI implementation could be a useful tool to analyse generated data. Yet, regulatory approval hurdles are in sight.
ByThe frequency of sentences related to AI between July 2021 and June 2022 was 421% higher than in 2016.
ByJohnson & Johnson was the top AI innovator in the clinical trial operations sector in the latest quarter.
ByThe number of roles in North America made up 52.8% of total AI jobs - up from 47.5% in the…
ByThis marks a deceleration in growth from the 7.1% decrease in deals that occurred in H2 2021 relative to the…
ByThe latest figure is higher than the 40.5% of companies who were hiring for AI related jobs a year ago.
ByConcept: German energy company Graforce has developed a plasma electrolysis technology that can convert methane and wastewater into hydrogen. The…
Concept: Indian tech startup DaveAI has launched a virtual avatar sales experience platform to assist businesses in developing a digital…
Thank you for subscribing to Clinical Trials Arena